Floatz logo

Marcaine

Pudendal Neuralgia

University of LouisvilleSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Pudendal Neuralgia cohort.

Asset / SponsorPhaseRating
Lidocaine
Groupe Hospitalier Diaconesses Croix Saint-Simon
Phase 4BBB
Physiologic Sodium Chloride Solution
Nantes University Hospital
Phase 4BB
Gabapentin
Cairo University
N/AD

Same molecule, other indications

Marcaine is also rated in:

migraine disorderActive
BBB
Indicative · Phase 4
74 / 100
View asset →
neuralgiaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
headache disorderActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →